19
Participants
Start Date
January 12, 2023
Primary Completion Date
August 30, 2026
Study Completion Date
December 30, 2026
TR64
TR64 tablets will be given daily for 28 days in 28-day cycles until there appears evidence of progressive disease, intolerable toxicity, or the subject discontinues from the study treatment for other reasons.
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Tarapeutics Science Inc.
INDUSTRY